Skip to main content

Gemini DRC NH01 Genetic Screening and Registry Study to Evaluate Long-term Clinical Outcomes and Disease Progression in Subjects with Non-central GA Who Are Carriers of High-risk Genetic Complement Variants Associated with Dry AMD

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Gemini Therapeutics

Start Date

October 10, 2018

End Date

October 18, 2022
 

Administered By

Ophthalmology

Awarded By

Gemini Therapeutics

Start Date

October 10, 2018

End Date

October 18, 2022